- Home
- SUUN vs ATLN Comparison
SUUN vs ATLN Comparison
Compare SUUN & ATLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUUN
- ATLN
- Stock Information
- Founded
- SUUN 2013
- ATLN 2014
- Country
- SUUN Canada
- ATLN United States
- Employees
- SUUN N/A
- ATLN N/A
- Industry
- SUUN
- ATLN
- Sector
- SUUN
- ATLN
- Exchange
- SUUN Nasdaq
- ATLN NYSE
- Market Cap
- SUUN 141.2M
- ATLN 137.6M
- IPO Year
- SUUN N/A
- ATLN 2021
- Fundamental
- Price
- SUUN $2.46
- ATLN $4.19
- Analyst Decision
- SUUN Strong Buy
- ATLN
- Analyst Count
- SUUN 1
- ATLN 0
- Target Price
- SUUN $6.00
- ATLN N/A
- AVG Volume (30 Days)
- SUUN 249.9K
- ATLN 69.5K
- Earning Date
- SUUN 05-14-2025
- ATLN 01-01-0001
- Dividend Yield
- SUUN N/A
- ATLN N/A
- EPS Growth
- SUUN N/A
- ATLN N/A
- EPS
- SUUN N/A
- ATLN N/A
- Revenue
- SUUN $36,247,013.00
- ATLN $442,609,814.00
- Revenue This Year
- SUUN $32.05
- ATLN N/A
- Revenue Next Year
- SUUN $72.25
- ATLN N/A
- P/E Ratio
- SUUN N/A
- ATLN N/A
- Revenue Growth
- SUUN 43.76
- ATLN 10.27
- 52 Week Low
- SUUN $1.95
- ATLN $1.30
- 52 Week High
- SUUN $7.50
- ATLN $8.98
- Technical
- Relative Strength Index (RSI)
- SUUN 34.53
- ATLN N/A
- Support Level
- SUUN $2.25
- ATLN N/A
- Resistance Level
- SUUN $2.53
- ATLN N/A
- Average True Range (ATR)
- SUUN 0.42
- ATLN 0.00
- MACD
- SUUN -0.18
- ATLN 0.00
- Stochastic Oscillator
- SUUN 10.28
- ATLN 0.00
About SUUN SolarBank Corporation Common Stock
SolarBank Corp is an independent renewable and clean energy project developer and asset operator based in Canada and the United States. It is engaged in the development and operation of solar photovoltaic power generation projects in the province of Ontario and the state of New York. The company operates in two principal geographical areas - Canada and United States with a substantial portion of its overall revenue being generated from United States.
About ATLN ATLANTIC INTERNATIONAL CORP
Atlantic International Corp formerly SeqLL Inc is a technology company providing life sciences instrumentation and research services in collaborative partnerships aimed at the development of novel scientific assets and intellectual property across multiple omics fields. The company leverages its expertise with the True Single Molecule Sequencing platform to empower scientists and researchers with improved genetic tools to greater understand the molecular mechanisms of disease that is essential to the continued development of new breakthroughs in genomic medicine, and that hopefully address the critical concerns involved with precision medicine.